Insights

Small team, high upside The company is a small to mid startup with 2-10 employees and a $17M funding round, indicating runway for partnerships and pilot programs in early-stage neurodelivery and post-operative pain solutions.

Niche product focus Lead platform NeuroRelease targets non-opiate drug delivery for post-operative and chronic pain, presenting a clear value proposition for collaboration with contract manufacturers, device integrators, and research institutions seeking alternatives to opioids.

Clinical and preclinical stage Advancing to pre-clinical validation for sustained release suggests opportunities to engage with CROs, academic collaborators, and early-phase clinical trial networks to accelerate development and reduce time to IND.

Strategic funding leverage With $17M in funding and modest revenue, there is room to pursue co-development, licensing, or milestone-based partnerships with larger pharma companies looking to augment their pain management or neurology portfolios.

Tech and regulatory readiness The technology stack and regulatory-driven field (neurodelivery, medical devices, and biologics) signal potential for partnerships around device integration, manufacturing scalability, quality systems, and regulatory strategy support.

Similar companies to Reynolds Therapeutics

Reynolds Therapeutics Tech Stack

Reynolds Therapeutics uses 8 technology products and services including WordPress, MySQL, Google Fonts API, and more. Explore Reynolds Therapeutics's tech stack below.

  • Content Management System
  • MySQL
    Database
  • Google Fonts API
    Font Scripts
  • Infrastructure As A Service
  • jQuery
    Javascript Libraries
  • jQuery Migrate
    Javascript Libraries
  • PHP
    Programming Languages
  • Facebook
    Widgets

Reynolds Therapeutics's Email Address Formats

Reynolds Therapeutics uses at least 4 email formats:
Reynolds Therapeutics Email FormatsExamplePercentage
FLast@pixarbio.comJDoe@pixarbio.com
83%
Last@pixarbio.comDoe@pixarbio.com
9%
First_Last@pixarbio.comJohn_Doe@pixarbio.com
4%
First@pixarbio.comJohn@pixarbio.com
4%

Frequently Asked Questions

What is Reynolds Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Reynolds Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Reynolds Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Reynolds Therapeutics's official website is reynoldstherapeutics.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Reynolds Therapeutics generate?

Minus sign iconPlus sign icon
As of October 2026, Reynolds Therapeutics's annual revenue is estimated to be <$1M.

What is Reynolds Therapeutics's SIC code and NAICS code?

Minus sign iconPlus sign icon
Reynolds Therapeutics's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Reynolds Therapeutics have currently?

Minus sign iconPlus sign icon
As of October 2026, Reynolds Therapeutics has approximately 2 employees across 1 continents, including North America. Key team members include Senior Vice President Innovation: K. H., Laboratory Manager: I. W. and Senior Neuroscientist: G. C. Explore Reynolds Therapeutics's employee directory with LeadIQ.

What industry does Reynolds Therapeutics belong to?

Minus sign iconPlus sign icon
Reynolds Therapeutics operates in the Pharmaceutical Manufacturing industry.

What technology does Reynolds Therapeutics use?

Minus sign iconPlus sign icon
Reynolds Therapeutics's tech stack includes WordPress, MySQL, Google Fonts API, Google Cloud, jQuery, jQuery Migrate, PHP and Facebook.

What is Reynolds Therapeutics's email format?

Minus sign iconPlus sign icon
Reynolds Therapeutics's email format typically follows the pattern of FLast@pixarbio.com. Find more Reynolds Therapeutics email formats with LeadIQ.

How much funding has Reynolds Therapeutics raised to date?

Minus sign iconPlus sign icon
As of October 2026, Reynolds Therapeutics has raised $17M in funding. The last funding round occurred on Nov 18, 2016 for $7M.

When was Reynolds Therapeutics founded?

Minus sign iconPlus sign icon
Reynolds Therapeutics was founded in 2013.
Reynolds Therapeutics logo

Reynolds Therapeutics

Pharmaceutical ManufacturingFlorida, United States2-10 Employees

Reynolds Therapeutics is a small pharmaceutical manufacturing company based in Fort Myers, Florida, focused on developing NeuroRelease, a neurological drug-delivery platform. The platform aims to deliver non-opioid medications in a targeted, sustained manner for postoperative pain as well as acute and chronic pain, with evidence drawn from pre-clinical models.

Founded by Frank Reynolds, the organization develops delivery systems for drugs, devices, or biologics intended to treat pain and several neurological conditions, including epilepsy, Parkinson’s disease, and spinal cord injury. The firm operates with a compact team and is positioned within the pharmaceutical manufacturing sector as it pursues neurological and pain-management applications of its delivery technology.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2013
Employees
2-10

Section iconFunding & Financials

  • $17M

    Reynolds Therapeutics has raised a total of $17M of funding over 2 rounds. Their latest funding round was raised on Nov 18, 2016 in the amount of $7M as a Post IPO Equity.

  • <$1M

    Reynolds Therapeutics's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.